OTraces - Model CDx - Highly Automated Testing Instrument
This highly automated testing instrument is manufactured to company specifications by Hamilton Company, producing an accurate diagnosis without human interpretation. Hamilton has been as strong supporter of OTraces, having provided all customization, programming and support at no cost, so that OTraces could transfer the immunoassay methods to the Hamilton high speed ELISA robot.
-
Most popular related searches
Product Details
The CDx is designed to optimize the performance and predictive power of the OTraces’ cancer screening reagent test kits. The system allows completion of one full run of all 5 immunoassays in the test panel in one shift, with no operator intervention after initial setup. In production configuration, the system will complete 80 cancers scores per day. When OTraces reaches full population screening level, production throughput will need to increase to at least 300 cancer scores per day. The Hamilton group of systems in this category is scalable so increasing this important parameter can be done when needed.
The OTraces technology measures blood protein biomarkers at unusually low levels of concentration, and uses biomarkers that have deep functional connections to immune response which OTraces uses as a virtual stethoscope on early detection and the various aspects of the disease process. The process of converting this data into highly accurate test results is performed remotely, using algorithms and software centrally stored in U.S. based servers by Bio-IT Solutions, Inc. exclusively and on OTraces’ behalf.
Customer reviews
No reviews were found for OTraces - Model CDx - Highly Automated Testing Instrument. Be the first to review!